Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
International Immunopharmacology|September 19, 2015
Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivativesIgor A Schepetkin, Andrei I Khlebnikov, Liliya N Kirpotina, et al.Microbes and Infection|April 22, 2009
Inhibition of the human neutrophil NADPH oxidase by Coxiella burnetiiDaniel W Siemsen, Liliya N Kirpotina, Mark A Jutila, et al.Journal of Medicinal Chemistry|August 18, 2006
Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screeningIgor A Schepetkin, Andrei I Khlebnikov, Liliya N Kirpotina, et al.Bioorganic & Medicinal Chemistry|September 26, 2008
Computational structure-activity relationship analysis of non-peptide inducers of macrophage tumor necrosis factor-alpha productionAndrei I Khlebnikov, Igor A Schepetkin, Liliya N Kirpotina, et al.Methods in Molecular Biology (Clifton, N.J.)|November 16, 2019
Analysis of Neutrophil Transmigration Through Epithelial Cell MonolayersLiliya N Kirpotina, Douglas J Kominsky, Mark T Quinn, et al.Molecular Pharmacology|January 19, 2007
High-throughput screening for small-molecule activators of neutrophils: identification of novel N-formyl peptide receptor agonistsIgor A Schepetkin, Liliya N Kirpotina, Andrei I Khlebnikov, et al.Methods in Molecular Biology (Clifton, N.J.)|May 6, 2008
Neutrophil isolation from nonhuman speciesDaniel W Siemsen, Igor A Schepetkin, Liliya N Kirpotina, et al.Molecules (Basel, Switzerland)|May 15, 2019
Neutrophil Immunomodulatory Activity of Natural Organosulfur CompoundsIgor A Schepetkin, Liliya N Kirpotina, Andrei I Khlebnikov, et al.Bioorganic & Medicinal Chemistry|December 15, 2006
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systemsAndrei I Khlebnikov, Igor A Schepetkin, Nina G Domina, et al.The Journal of Pharmacology and Experimental Therapeutics|September 26, 2009
Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanismDean Y Maeda, Mark T Quinn, Igor A Schepetkin, et al.Pageof 8